A set of 10 molecules in blood could be used to predict with 90% accuracy whether people are at greater risk of developing dementia within the next few years, according to researchers at Georgetown University Medical Center, USA.
The study, published in Nature Medicine, shows differences in the blood between people with pre-clinical Alzheimer’s disease before the presenting symptoms appear and people who will not go on to develop the condition.